Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Homozygous Familial Hypercholesterolemia (HoFH) to Metabolic Disorders Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Homozygous Familial Hypercholesterolemia (HoFH) to Metabolic Disorders Clinical Trials 20
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 27
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Homozygous Familial Hypercholesterolemia (HoFH) Therapeutics Clinical Trials 32
Prominent Drugs 34
Latest Clinical Trials News on Homozygous Familial Hypercholesterolemia (HoFH) 35
Aug 23, 2017: New Economic Alysis Based On Repatha (Evolocumab) Outcomes Data Published In JAMA Cardiology 35
Jul 25, 2017: Newly Published Long-term Study Shows Highly Positive Results for Lojuxta 35
Jun 28, 2017: Gemphire Announces Top-Line Data from COBALT-1 Phase 2b Clinical Trial in HoFH Patients 36
Clinical Trial Profile Spshots 38
Appendix 103
Abbreviations 103
Definitions 103
Research Methodology 104
Secondary Research 104
About GlobalData 105
Contact Us 105
Source 105